A Double-Blind, Placebo-Controlled, Single-Dose Escalation and Food Effect Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ONO-6950 in Healthy Adult Subjects.
Phase of Trial: Phase I
Latest Information Update: 12 Jun 2012
At a glance
- Drugs Gemilukast (Primary)
- Indications Asthma
- Focus Adverse reactions
- 30 Jun 2011 Actual end date (Jun 2011) added as reported by ClinicalTrials.gov.
- 30 Jun 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 23 Feb 2011 New trial record